Serum Concentrations of Antimycobacterial Drugs in Patients with Pulmonary Tuberculosis in Botswana

2005150 citationsJournal Articlebronze Open Access

Authors

Jordan W. Tappero · Centers for Disease Control and Prevention

Williamson Z. Bradford · San Francisco General Hospital

Tracy Agerton · Centers for Disease Control and Prevention

Philip C. Hopewell · San Francisco General Hospital

Arthur Reingold · University of California, Berkeley

Shahin Lockman · Centers for Disease Control and Prevention

Adeola Oyewo

Abstract

These data, predominantly from HIV-infected patients with TB, suggest that low isoniazid, rifampin, and ethambutol concentrations are common in Botswana. In contrast, pyrazinamide usually is well absorbed.

Topics & Keywords

Tuberculosis Research and Epidemiology Pneumocystis jirovecii pneumonia detection and treatment Mycobacterium research and diagnosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 41, Issue 4, pp. 461-469

DOI: 10.1086/431984

Field-Weighted Citation Impact: 3.90